Bioequivalence and Bioavailability Forum 14:28 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Put the sickle to the corn [General Sta­tis­tics]

posted by Helmut Homepage - Vienna, Austria, 2018-02-13 01:37  - Posting: # 18409
Views: 5,238

Dear Astea,

may I call you Nasty as well?

» I may suppose there were some problems in your Acetylsalicylic acid study - may be in stability…

Samples put in an ice-bath until centrifugation, plasma diluted 1:1 with 5% o-phosphoric acid for stabilization.

» … or inadequate sampling time,

Hhm. 00:05, 00:10, 00:15, 00:20, 00:30, 00:40, 00:50, 01:00, 01:20, 01:40, 02:00, 02:30, 03:00, 04:00, 06:00, 08:00, 10:00, 12:00 hours. No problems with "first point Cmax".


» … did you measure also salicylic acid?

Sure. Nice rho (see in the list above).

[image]

» What was the dose?

100 mg ASA (actually 5 × 20 mg tablets).

I recalculated the entire study (October 1997!) from raw-data (nasty!). Maximum residual AUC in any of the 24 subjects 7%. CVintra: ASA 18.3% (Cmax), 11.8% (AUC0–t); SA 9.58% (Cmax), 8.71% (AUC0–t). Both ASA and SA passed BE with flying colors.

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,883 posts in 4,027 threads, 1,271 registered users;
online 28 (0 registered, 28 guests [including 27 identified bots]).

Those who make no mistakes are making the biggest mistakes of all –
they are attempting nothing new.    Anthony de Mello

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed